Graham Mills
← Back to Team

Graham Mills


Venture Capital
Aron Schmidt

Graham joined Abingworth’s London office in January 2022 working with the transatlantic team in evaluating new investment opportunities and to support existing portfolio companies in a therapeutic area-agnostic approach.

Previously, Graham was Founder & Managing Director at healthcare-focused tech startup, where he built significant experience in scaling early stage ventures and navigating the challenges through development. Before & alongside this, Graham worked actively in the investment teams of JJDC and Seroba Life Sciences, developing broad investment theses through new opportunity evaluation and detailed therapeutic landscape analyses.

Graham holds a PhD in Medical Biology from the University of Cambridge, an MRes in Translational Cancer Medicine from King’s College London, a BA in Genetics from Trinity College Dublin, and an MBA from the Quantic School of Business & Technology.